Observational studyBMC musculoskeletal disorders2025
Short-term clinical efficacy of unilateral biportal endoscopic unilateral laminectomy for bilateral decompression for lumbar epidural lipomatosis: an observational study.
Observational study in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Early MRI-Detected Interspinous Ligament Region Edema Is Associated With Delayed Pain Recovery and Persistent Low Back Pain After Unilateral Biportal Endoscopic Surgery.Pain and therapy · 2026Article
- Lumbar spinal stenosis exacerbated by spinal epidural lipomatosis: a case report.Frontiers in surgery · 2026Article
- Case Report: Spinal epidural lipomatosis with incomplete cauda equina syndrome treated with unilateral biportal endoscopic technique.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveEvaluation of Multidimensional Clinical Outcomes Following Unilateral Biportal Endoscopic Unilateral Laminectomy for Bilateral Decompression (UBE-ULBD) for Symptomatic Lumbar Epidural Lipomatosis .
methodsThis retrospective study analyzed 15 consecutive patients with lumbar epidural lipomatosis (LEL) who underwent UBE-ULBD between February 2021 and November 2023. Demographic data, surgical techniques, radiographic parameters, and patient-reported outcomes were systematically reviewed. MRI was used to measure the Cross Sectional Area (CSA) of dural sac and paravertebral muscle to evaluate the decompression effect. The range of postoperative spinal canal decompression extent and facet joint preservation rate were evaluated by CT. Dynamic X-ray measurement of intervertebral mobility to assess lumbar stability. Visual Analogue Scale (VAS) was used to evaluate the relief degree of for low back/leg pain at preoperative and postoperative 1/3/6/12-month intervals. Oswestry Disability Index (ODI) and Japanese Orthopaedic Association Scores (JOA) were used to evaluate the functional recovery. Fischgrund criteria were used to determine the global clinical efficacy grading. Group comparisons were performed using repeated-measures ANOVA and paired-samples t-tests. Categorical variables were presented as frequencies (percentages). Statistical significance was defined as P < 0.05.
resultsAll 15 patients successfully underwent UBE-ULBD, achieving complete removal of adipose tissue in the compressed segments. Each patient was followed for a minimum of 12 months postoperatively. Postoperative CSA of the dural sac was significantly larger than preoperative values (p < 0.001). The atrophy rate of the paraspinal muscles was 4.92%, and 77.78% of facet joints were preserved. No lumbar instability occurred during follow-up. VAS scores for low back and leg pain improved significantly from (7.37 ± 0.62) and (6.31 ± 0.38) preoperatively to (1.46 ± 0.20) and (1.49 ± 0.14) at 12 months postoperatively (P < 0.05). ODI scores improved significantly from (67.93 ± 2.40) preoperatively to (16.60 ± 2.06) at 1 year (P < 0.05). Similarly, JOA scores improved from (8.73 ± 1.94) to (25.93 ± 0.80) (P < 0.05). According to the Fischgrund criteria, 5 patients had excellent outcomes, 8 had good outcomes, 2 had fair outcomes, and the overall Good-to-excellent rate was 86.67%. One patient experienced incisional adipose tissue liquefaction with persistent drainage, which resolved after wound debridement and anti-inflammatory therapy. All patients were free of Complications such as cauda equina injury or cerebrospinal fluid leakage.
conclusionUBE-ULBD demonstrates excellent clinical and radiological outcomes in LEL patients, with minimal complications, making it an effective treatment option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.